- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Cholesterol
Volume 2011 (2011), Article ID 286875, 4 pages
doi:10.1155/2011/286875
Rosiglitazone and Fenofibrate Additive Effects on Lipids
1Cardiology Service, Brooke Army Medical Center, San Antonio, TX 78234-6200, USA
2Cardiology Service MCHE-MDC, Brooke Army Medical Center, 3851 Roger Brooke Drive, San Antonio, TX 78234-6200, USA
3Cardiology Service, Walter Reed Army Medical Center, Bethesda, MD 20889-5600, USA
Received 7 September 2011; Accepted 5 October 2011
Academic Editor: Jeffrey Cohn
Copyright © 2011 Ahmad Slim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Ahmad Slim, Laudino Castillo-Rojas, Eddie Hulten, Jennifer N. Slim, Dorette Pearce Moore, and Todd C. Villines, “Rosiglitazone and Fenofibrate Additive Effects on Lipids,” Cholesterol, vol. 2011, Article ID 286875, 4 pages, 2011. doi:10.1155/2011/286875